SUNEKOS INTICARE

The main benefits of SUNEKOS INTICARE are:
- Vulvo-vaginal tissue regeneration.
- Thanks to non-crosslinked hyaluronic acid, it keeps the mucous membrane and skin lubricated and soft.
- Improved elasticity and comfort.
- It promotes tissue well-being without changing the natural shape or volume.
- Minimally invasive procedure.

- PROFESSIONAL DIETETICS S.P.A.
- NAME: SUNEKOS INTICARE
- COMPOSITION: Non-cross-linked low-molecular-weight hyaluronic acid, Glycine, L-Proline, L-Lysine, L-Leucine, L-Valine, L-Alanine patented formula 6AA.
- PRESENTATION: 2 x 3 ml; 2 x 100 mg.
- NEEDLES: Needle 13 mm 30-32 G for injections into the labia majora.
4 mm 30-32 G needle for micro-injections into the vaginal vestibule and vaginal wall mucosa.
- INDICATIONS: Indicated for the treatment of vulvovaginal atrophy. It improves vaginal dryness, itching, burning and dyspareunia.
- INJECTION DEPTH: Larger lips: subcutaneous injection in the outer soft tissue area (standard depth for subcutaneous tissue) with 13 mm needle.
Vaginal vestibule: shallow micro-injections into the vestibular area with a 4 mm needle.
Introitus and vaginal walls: very superficial intra-mucosal micro-injections (about 2 mm deep into the mucosa).
- DURATION: Clinical results are progressively evaluated according to the regeneration and tonicity of the treated tissues.
- USE: Strict medical use.

- Vials: 2 x 3 ml sterile sodium hyaluronate gel.
- Vials: 2 x 100 mg sterile freeze-dried amino acid mixture.

labia majora, labia minora, vulvar vestibule, vaginal introitus, vaginal walls.

Low-molecular-weight non-cross-linked hyaluronic acid, Glycine, L-Proline, L-Lysine, L-Leucine, L-Valine, L-Alanine patented 6AA formula.

- Use only by a qualified physician or healthcare professional with expertise in vulvo-vaginal injections and treatment.
- Carefully evaluate the patient's clinical history before treatment.
- Avoid injections in areas with compromised skin or mucous tissue or open lesions.
- Inform the patient about possible local reactions such as swelling, erythema or bruising that may occur after injection.
- Consider discontinuing medications that increase bleeding (only if authorised by the treating physician) before the procedure.

- Known hypersensitivity or allergy to one or more components of the formulation (hyaluronic acid or amino acids).
- Infection, inflammation or pathological changes in the area to be treated.
- Pregnancy and lactation.
- Clotting disorders or taking anticoagulants that may increase bleeding/bleeding.
- Patients with systemic conditions or autoimmune diseases that contraindicate injection procedures without specific clinical evaluation.

Sunekos Inticare is specifically indicated for the treatment of vaginal dryness and vaginal atrophy, which can cause symptoms such as itching, burning, pain during sexual intercourse and irritation.
The patented HY6AA formula with non-cross-linked hyaluronic acid (HA) and amino acids (AA) is designed to reconstruct the extracellular matrix (ECM) of the mucous membrane of the vulvovaginal area, ensuring long-lasting physiological hydration.
The treatment restores physiological hydration and intimate well-being, improving the quality of daily life.